Urgent: Hydroxycut Class Action Have Already Been Filed
On May one, 2009, there had been a recall of fourteen Hydroxycut diet-aid products coming from a number of reports that folks using the products were developing heavy liver problems and other health worries. Less than a week later, on May 4, the first Hydroxycut class action suit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company negligence in informing the public about potential perils of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it did not reveal to customers, it should definitely be held accountable.
A class action lawsuit is filed by a group of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less expensive, than filing an individual suit. As a rule, filing a class action legal action will not cost anything unless there’s a settlement. At that time, the lawyer who handled the suit will take his fees from the compensation that got given and then share the remaining funds to the litigants in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the reasons that class action suits became so popular.
The first class action legal action against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall occurred in the United States where 23 cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive seventeen reports concerning folks who sustained respiratory, neurological, heart, and gut problems as a consequence of Canadians using the products.
The Hydroxycut class action suit alleges the company sold the products without correctly informing the general public of the health risks that they could exposing shoppers to. The complaint states the company did not publish the data on the product labels stating that users could run the chance of liver and kidney damage as well as gut, cardio, respiratory, and neurological problems. The suit goes on to claim this was an obvious omission on the part of the company which purposely misled clients concerning the safety of the products.











